GoalVest Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.6K Sell
82
-113
-58% -$45K 0.01% 262
2026
Q2
$70.6K Sell
195
-955
-83% -$327K 0.01% 181
2026
Q1
$405K Sell
1,150
-31
-3% -$11.1K 0.08% 108
2025
Q4
$387K Hold
1,181
– – 0.07% 113
2025
Q3
$333K Buy
1,181
+50
+4% +$14.5K 0.07% 110
2025
Q2
$316K Sell
1,131
-3
-0.3% -$850 0.08% 104
2025
Q1
$353K Sell
1,134
-68
-6% -$20.1K 0.1% 92
2024
Q4
$313K Buy
1,202
+600
+100% +$178K 0.09% 98
2024
Q3
$194K Sell
602
-80
-12% -$26.2K 0.06% 108
2024
Q2
$213K Buy
682
+145
+27% +$42.6K 0.07% 97
2024
Q1
$153K Buy
537
+367
+216% +$107K 0.05% 125
2023
Q4
$49K Buy
170
+81
+91% +$22.1K 0.02% 140
2023
Q3
$23.9K Hold
89
– – 0.01% 201
2023
Q2
$19.8K Buy
+89
New +$20.7K 0.01% 202
2022
Q2
– Sell
-6
Closed -$1K – 312
2022
Q1
$1K Buy
+6
New +$1.38K ﹤0.01% 306
2021
Q1
– Sell
-1,767
Closed -$406K – 175
2020
Q4
$406K Hold
1,767
– – 0.34% 83

Other funds holding AMGN

GoalVest Advisory's AMGN Position: Q3 2026 in Review

GoalVest Advisory reduced its Amgen (AMGN) stake by 58% in Q3 2026, selling an estimated $45K and leaving 82 shares worth $34.6K. The position accounts for 0.01% of the portfolio, ranked #262.

GoalVest Advisory first reported a position in AMGN in Q4 2020 and has held it in 16 quarters since. The position peaked at $406K in Q4 2020. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • GoalVest Advisory held 82 shares of Amgen worth $34.6K as of Q3 2026.
  • GoalVest Advisory sold 113 Amgen shares in Q3 2026, an estimated $45K.
  • Amgen made up 0.01% of GoalVest Advisory's portfolio in Q3 2026, its #262 holding.
  • GoalVest Advisory first reported a position in Amgen in Q4 2020 and has held it in 16 quarters since.
  • GoalVest Advisory's Amgen position peaked at $406K in Q4 2020.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on GoalVest Advisory's 13F filing for Q3 2026, filed 2 Oct 2026.